Trexquant Investment LP - CELLDEX THERAPEUTICS INC NEW ownership

Back to all holdings Add to watchlist

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 189 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2015. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
Trexquant Investment LP ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2015$2,214,000
+159.3%
210,090
+519.7%
0.19%
+99.0%
Q2 2015$854,000
-64.6%
33,900
-60.9%
0.10%
-61.0%
Q1 2015$2,413,000
+112.8%
86,600
+39.3%
0.25%
+22.4%
Q4 2014$1,134,000–62,163–0.20%–
 Download
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q2 2015
NameSharesValueWeighting ↓
Byrne Asset Management LLC 86$2,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders